Researchers should be supported by an enthusiastic local research environment and by a UK-based mentor as part of a partnership between the African and UK institutions. Around 4,000 people are set to benefit from a step-change in treatment for early breast cancer following today’s provisional approval by NICE of abemaciclib in combination with hormone therapy as an option after surgery. Evidence-based recommendations developed by independent committees, including professionals and lay members, and consulted on by stakeholders.
- The Oxford 1+1 MBA programme is a unique, two-year graduate experience that combines the depth of a specialised, one-year master’s degree with the breadth of a top-ranking, one-year MBA.
- Findings from studies concerning health, illness, physical and psychological well-being of women, as well as the environmental, lifestyle, and socio-cultural factors.
- Get the latest advice about COVID-19, including information about symptoms, vaccination, NHS COVID Pass, and what to do if you have or might have